10 October 2018
Accrol Group Holdings plc
("Accrol Group", the "Company" or, together with its subsidiaries, the "Group")
AIM: ACRL
Appointment of Non-executive Director
Accrol Group, the UK's leading independent tissue converter, announces that Simon Allport, aged 54, has been appointed to the Board as an independent non-executive Director.
Simon has 32 years' experience in the professional services industry, first making partner at Arthur Andersen and rising to managing partner for the North of England and Scotland at Ernst & Young. He retired from Ernst & Young in 2017 and has since taken a small number of non-executive and consultancy roles.
Simon joins the Audit Committee with immediate effect.
The Board now comprises:
· Dan Wright (Executive Chairman)
· Gareth Jenkins (Chief Executive Officer)
· Steve Townsley (Chief Financial Officer)
· Joanne Lake (Independent Non-Executive Director)
· Euan Hamilton (Independent Non-Executive Director)
· Simon Allport (Independent Non-Executive Director)
Dan Wright, Executive Chairman of Accrol Group, said:
"Simon's appointment increases the capabilities and calibre of an already much strengthened Board. The depth of his commercial knowledge and experience, combined with his clear thinking and direct approach, will be stimulating and valuable, as we accelerate the turnaround process in H2 and begin to explore the strategic growth options for the Group. On behalf of everyone at Accrol, I welcome Simon to the Board."
Information on Simon required to be disclosed under Schedule Two, paragraph (g) (i)-(viii) of the AIM Rules for Companies:
Simon Allport is currently a director of the following companies:
· Fitzallan Limited
· The Enterprise Fund Limited
· Etale Limited
Simon is also a member of an independent advisory committee for Tosca Debt Capital LLP.
In addition, Simon was a partner in the following limited liability partnerships in the past five years:
· Ernst & Young Europe LLP
· Ernst & Young LLP
Simon has no interests in the share capital of Accrol Group Holdings plc.
There is no further information on Simon required to be disclosed under Schedule Two, paragraph (g) (i)-(viii) of the AIM Rules for Companies.
For further information, please contact: |
|
|
|
Accrol Group Holdings plc |
|
Dan Wright, Executive Chairman |
Tel: +44 (0) 1254 278 844 |
Gareth Jenkins, Chief Executive Officer |
|
Steve Townsley, Chief Financial Officer |
|
|
|
Zeus Capital Limited (Nominated Adviser & Broker) |
|
Dan Bate / Andrew Jones |
Tel: +44 (0) 161 831 1512 |
Dominic King / John Goold |
Tel: +44 (0) 203 829 5000 |
|
|
Belvedere Communications Limited |
|
Cat Valentine (cvalentine@belvederepr.com) |
Tel: +44 (0) 7715 769 078 |
Llew Angus (langus@belvederpr.com) |
Tel: +44 (0)7407 023 147 |
Notes to Editors
Accrol Group Holdings plc, based in Lancashire, is a leading tissue converter and supplier of toilet rolls, kitchen rolls and facial tissues, as well as other tissue products, to major discounters and grocery retailers throughout the UK.
Accrol operates from three sites:
· A manufacturing, storage and distribution facility in Blackburn;
· A facial tissue plant, also in Blackburn; and
· A manufacturing, storage and distribution facility in Leyland.